top of page
Search

Bismuth Subsalicylate Prices, Trends, News, Index & Market Analysis – Q2 2026

  • 49 minutes ago
  • 6 min read

According to ChemAnalyst, The Bismuth Subsalicylate Prices witnessed a generally firm trend during the second quarter of 2026, supported by stable pharmaceutical demand and fluctuations in the global bismuth supply chain. As an essential active pharmaceutical ingredient (API) widely used in over-the-counter gastrointestinal medications, Bismuth Subsalicylate continues to experience pricing movements that are closely tied to the availability of refined bismuth metal, mining activity, pharmaceutical production, and international trade dynamics.

China remained the dominant supplier of bismuth worldwide during the quarter, and any changes in Chinese production, environmental regulations, or export availability had a direct impact on global pricing. While APAC recorded notable price gains because of tightening raw material supply, North America and Europe maintained relatively firm pricing amid steady pharmaceutical demand and dependence on imported bismuth compounds.

The quarter was characterized by stable healthcare consumption, resilient pharmaceutical manufacturing, and moderate procurement activities from distributors, contributing to balanced market fundamentals despite upstream supply constraints.

Global Bismuth Subsalicylate Market Overview

Bismuth Subsalicylate is extensively used in pharmaceutical formulations designed to treat diarrhea, indigestion, upset stomach, nausea, and heartburn. It remains one of the most widely recognized ingredients in gastrointestinal medications across global healthcare markets.

The pricing of Bismuth Subsalicylate depends primarily on:

  • Availability of refined bismuth metal

  • Mining output of lead and tungsten (primary by-products producing bismuth)

  • Pharmaceutical manufacturing demand

  • Export availability from China

  • Logistics and freight costs

  • Currency movements

  • Environmental regulations affecting mining operations

  • Global healthcare consumption trends

During Q2 2026, these market drivers collectively shaped regional pricing trends across Asia-Pacific, North America, and Europe.

Get Real Time Online for Bismuth Subsalicylate Prices: https://www.chemanalyst.com/Pricing-data/bismuth-subsalicylate-2517

Bismuth Subsalicylate Prices in APAC – Q2 2026

The Asia-Pacific region experienced the strongest upward pricing movement during the second quarter of 2026.

In China, the Bismuth Subsalicylate Price Index increased by 11.98% quarter-over-quarter, reflecting tightening supplies of upstream bismuth materials and continued demand from pharmaceutical manufacturers.

Exporters reported the average Bismuth Subsalicylate price at approximately USD 35,236.67 per metric ton, highlighting the impact of constrained raw material availability across the region.

China continues to dominate global bismuth production, accounting for the majority of worldwide refined bismuth output. Since bismuth is primarily recovered as a by-product of lead, copper, and tungsten processing, fluctuations in mining operations significantly influence the supply of pharmaceutical-grade bismuth compounds.

Several factors contributed to the increase in Chinese prices during Q2 2026:

  • Reduced availability of refined bismuth

  • Higher production costs across mining operations

  • Stable domestic pharmaceutical demand

  • Consistent export orders

  • Tight inventories among suppliers

  • Moderate logistical expenses

Environmental regulations governing mining activities also continued to influence production rates, limiting additional supply growth despite healthy demand.

The pharmaceutical industry remained the principal consumer, with manufacturers maintaining regular procurement schedules to support production of gastrointestinal medicines for both domestic and export markets.

Bismuth Supply Continues to Drive Market Direction

Unlike many pharmaceutical intermediates that depend primarily on chemical feedstocks, Bismuth Subsalicylate pricing is heavily influenced by metal mining activities.

Since elemental bismuth is rarely mined independently, global availability depends largely on:

  • Lead mining

  • Tungsten extraction

  • Copper refining

  • Tin processing

Any reduction in production from these industries can tighten bismuth availability even if pharmaceutical demand remains unchanged.

During Q2 2026, several mining operations prioritized operational efficiency over production expansion, contributing to relatively limited raw material availability throughout Asia.

This structural dependence on by-product recovery continues to make global bismuth markets particularly sensitive to fluctuations in mining output.

Bismuth Subsalicylate Prices in North America – Q2 2026

North American Bismuth Subsalicylate prices remained stable to slightly firm throughout the quarter.

Steady demand from pharmaceutical manufacturers, healthcare companies, and over-the-counter medicine producers supported the market despite relatively balanced inventories.

The region remains highly dependent on imported bismuth materials because domestic primary bismuth production remains extremely limited.

Consequently, North American prices continued to reflect international market developments, particularly export trends from China.

Major pricing factors during the quarter included:

  • Stable pharmaceutical manufacturing

  • Consistent OTC medicine demand

  • Dependence on imported bismuth compounds

  • Balanced distributor inventories

  • Moderate logistics costs

  • Stable procurement activity

Importers maintained sufficient inventory levels, preventing significant price spikes despite stronger Asian pricing.

Healthcare demand remained resilient as pharmaceutical companies continued regular production schedules for gastrointestinal medications throughout the quarter.

Pharmaceutical Demand Supported Market Stability

Demand from the healthcare sector remained one of the strongest pillars supporting Bismuth Subsalicylate prices during Q2 2026.

The compound continues to be widely incorporated into:

  • Antidiarrheal medications

  • Upset stomach treatments

  • Digestive relief products

  • Antacid formulations

  • Gastrointestinal healthcare products

  • Hospital pharmaceutical formulations

The over-the-counter (OTC) healthcare segment maintained healthy sales across developed markets, ensuring consistent purchasing activity among pharmaceutical manufacturers.

Since gastrointestinal disorders remain common globally, consumption patterns remained relatively predictable, helping stabilize market demand despite fluctuations in upstream supply.

Bismuth Subsalicylate Prices in Europe – Q2 2026

European Bismuth Subsalicylate prices remained firm during the second quarter of 2026.

The market was supported by:

  • Stable pharmaceutical demand

  • Elevated upstream bismuth costs

  • Dependence on imported raw materials

  • Consistent procurement by pharmaceutical manufacturers

Europe continues to rely heavily on imported bismuth compounds due to limited domestic production capacity.

China remained the primary global supplier, making European buyers particularly sensitive to supply changes occurring within the Chinese mining and refining industries.

Importers maintained relatively balanced inventories during the quarter, preventing excessive market volatility despite higher raw material costs.

The healthcare sector continued regular purchasing patterns, supporting stable market fundamentals across the region.

Supply Chain and Trade Developments

Global trade flows remained an important factor influencing Bismuth Subsalicylate pricing during Q2 2026.

International exporters focused on fulfilling pharmaceutical contracts while navigating evolving logistics conditions.

Several market dynamics influenced supply:

  • Tight upstream bismuth availability

  • Stable export shipments

  • Balanced global inventories

  • Predictable pharmaceutical procurement

  • Moderate freight rates

  • Controlled inventory management

Although logistics costs remained manageable compared to previous years, exporters continued to carefully allocate available supplies toward higher-value pharmaceutical markets.

Raw Material Market Outlook

Refined bismuth remains the most important raw material affecting Bismuth Subsalicylate production economics.

Since production depends on by-product recovery, supply cannot always increase rapidly in response to stronger pharmaceutical demand.

Key factors influencing raw material pricing include:

  • Lead production levels

  • Tungsten mining activity

  • Copper refining output

  • Environmental regulations

  • Global mining investments

  • Export policies

  • Metal processing capacity

During Q2 2026, tighter bismuth availability contributed to stronger pricing across Asia while maintaining firm market sentiment globally.

Factors Influencing Bismuth Subsalicylate Prices

Several interconnected factors determined pricing movements during the quarter:

Raw Material Availability

The limited availability of refined bismuth remained the largest pricing driver worldwide.

Pharmaceutical Industry Demand

Steady production of gastrointestinal medications supported consistent procurement.

Chinese Export Supply

As the world's leading producer, China's export availability significantly influenced international markets.

Mining Industry Performance

Since bismuth is produced as a by-product, mining activity in other metals directly affects supply.

International Trade

Import-dependent regions remained sensitive to global shipping schedules and export availability.

Inventory Levels

Balanced inventories helped prevent excessive market volatility across North America and Europe.

Market Challenges

Despite relatively healthy demand, several challenges persisted throughout Q2 2026.

These included:

  • Limited primary bismuth production

  • Dependence on by-product mining

  • Supply concentration in China

  • Rising mining costs

  • Environmental compliance requirements

  • Raw material availability risks

These structural challenges continue to influence long-term pricing patterns across the global Bismuth Subsalicylate market.

Market Outlook

Looking ahead, the Bismuth Subsalicylate Prices are expected to remain relatively firm in the coming quarters.

Pharmaceutical demand is projected to remain stable due to continued consumption of gastrointestinal healthcare products worldwide. Meanwhile, the availability of refined bismuth is expected to remain the critical determinant of future price movements.

Any disruption in Chinese exports, mining operations, or by-product recovery from lead and tungsten production could tighten global supply and support higher prices.

On the demand side, expanding healthcare access, increasing pharmaceutical manufacturing, and sustained OTC medicine consumption are likely to provide ongoing market support.

Overall, while dramatic price volatility is not anticipated under current market conditions, the combination of constrained raw material availability and stable pharmaceutical demand is expected to keep the global Bismuth Subsalicylate market on a firm footing through the remainder of 2026.

Conclusion

The Bismuth Subsalicylate Prices during Q2 2026 (Quarter Ending June 2026) reflected a market supported by resilient pharmaceutical demand and constrained upstream bismuth availability. China led the price gains, recording an 11.98% quarter-over-quarter increase, with exporters reporting an average price of approximately USD 35,236.67/MT. North America maintained stable to slightly firm pricing, underpinned by steady healthcare demand despite its reliance on imported bismuth materials. Europe also experienced firm market conditions as higher raw material costs and continued dependence on Chinese supply sustained pricing levels. Going forward, global Bismuth Subsalicylate prices are expected to remain supported by balanced pharmaceutical demand, evolving mining output, and the availability of refined bismuth, ensuring continued market stability in the near term. 



About Us:

Welcome to ChemAnalyst, a next–generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as “Product Innovator of the Year 2023” and ranked among the “Top 100 Digital Procurement Solutions Companies,” we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

Contact Us:

Address:

420 Lexington Avenue, Suite 300 New York, NY 10170 United States

Phone: +1 332 258 6602

Comments

bottom of page